Otofarma (OTO) Stock Overview

Engages in production and distribution of custom-made hearing aids. More details

OTO fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (€31M)

OTO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Otofarma S.P.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Otofarma
Historical stock prices
Current Share Price	€5.40
52 Week High	€7.00
52 Week Low	€5.34
Beta	0
1 Month Change	-1.82%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-11.48%

Recent updates

Shareholder Returns

	OTO	IT Medical Equipment	IT Market
7D	-1.8%	-2.3%	1.4%
1Y	n/a	-19.4%	24.3%

Return vs Industry: Insufficient data to determine how OTO performed against the Italian Medical Equipment industry.

Return vs Market: Insufficient data to determine how OTO performed against the Italian Market.

Price Volatility

Is OTO's price volatile compared to industry and market?
OTO volatility
OTO Average Weekly Movement	5.0%
Medical Equipment Industry Average Movement	4.0%
Market Average Movement	4.1%
10% most volatile stocks in IT Market	7.7%
10% least volatile stocks in IT Market	2.3%

Stable Share Price: OTO has not had significant price volatility in the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine OTO's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	n/a	Giovanna Bartolomucci	www.otofarmaspa.com

Otofarma S.P.A. engages in production and distribution of custom-made hearing aids. The company provides hearing aid solutions including, custom-made, in-the-canal, and behind-the-ear hearing aids, rechargeable hearing aids, and distributes complementary accessories. The company was incorporated in 2016 and is based in Napoli, Italy with an additional office in Milan, Italy.

Otofarma S.P.A. Fundamentals Summary

How do Otofarma's earnings and revenue compare to its market cap?
OTO fundamental statistics
Market cap	€31.09m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is OTO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OTO income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did OTO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/02 20:12
End of Day Share Price	2025/10/31 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Otofarma S.P.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Otofarma S.P.A.BIT:OTO Stock Report